IODOSORB^◊ Ointment is a sterile formulation of Cadexomer Iodine. When applied to the wound, IODOSORB^◊ cleans it by absorbing fluids, removing exudate, pus and debris and forming a gel over the wound surface. As the ointment swells, iodine is released, killing bacteria and changing colour.

IODOSORB^◊ ointment contains 50% cadexomer iodine and 50% ointment base.

Helps Promote Wound Healing

• Pus and Debris is removed effectively.
• IODOSORB^◊ helps to promote a clean wound healing environment.
• A change in colour indicates when IODOSORB^◊ should be changed.
• Gel formed over the wound helps to facilitate moist healing.
• Accelerated healing rates can lead to earlier patient discharges.

Patient comfort

• IODOSORB^◊ ointment treats infection, associated pain is reduced which can improve quality of life.
• IODOSORB^◊ is a non-adhesive which can reduce trauma when product is changed encouraging patient compliance.

IODOSORB^◊ ointment - For the treatment of chronic leg ulcers.

As IODOSORB^◊ Ointment contains 0.9% w/w iodine it should not be used in patients with known or suspected Iodine sensitivity. IODOSORB^◊ Ointment  is contraindicated in Hashimoto's Thyroiditis.

In patients with a prior history of Graves Disease it is not recommended to use iodine containing products, which includes IODOSORB^◊ Ointment.

The ointment should not be used in the case of non-toxic nodular goitre.
Patients with a past history of any thyroid disorder are more susceptible to alteration in thyroid metabolism with chronic IODOSORB^◊ therapy.

Iodine is absorbed systemically especially when large wounds are treated.

In endemic goitre there has been isolated reports of hyperthyroidism associated with IODOSORB^◊.

There is a potential for interaction of iodine with the following drugs and therefore co-administration is not recommended, Lithium, Sulphafurazoles and Sulphonylureas.

It has been observed occasionally that an adherent crust can form when the dressing is not changed with significant frequency.
Iodine can cross the placental barrier and is secreted into milk.  Do not use IODOSORB^◊ in pregnant or lactating women.